Semaglutide represents an exciting new breakthrough in weight loss
Zepbound: Doubling the Hormonal Action Zepbound, a new weight loss medication, combines GLP-1 and GIP hormone action, enhancing weight loss results
Alcohol consumption can impair the liver's ability to produce glucose through gluconeogenesis, especially during fasting states or several hours after drinking
Hypothetical Molecular Mechanisms Underlying Hyperhomocysteinemia-Mediated Vascular Disorders Hyperhomocysteinemia-Mediated Oxidant Stress through Imbalanced Thiol Redox Status Numerous studies indicate that oxidant stress plays a role in the development of occlusive atherosclerotic lesions that are observed primarily in homozygotes for the CBS defect (McCully, 1983) and later in experimental hyperhomocysteinemia
Fox CK, Kaizer AM, Rudser KD, Nathan BM, Gross AC, Sunni M, et al
Healthcare providers can work collaboratively with patients to optimize glycemic control, address modifiable risk factors, and implement preventive strategies while continuing beneficial weight management therapy